0,718  0,022  Caspase 9 stimulant
0,615  0,013  5 Hydroxytryptamine release stimulant
0,599  0,023  Alzheimer's disease treatment
0,567  0,004  5 Hydroxytryptamine agonist
0,552  0,019  5 Hydroxytryptamine release inhibitor
0,554  0,023  Mood disorders treatment
0,547  0,028  Antiparkinsonian
0,536  0,034  GST A substrate
0,525  0,024  Antidepressant
0,521  0,021  GABA C receptor rho-3 antagonist
0,492  0,034  Aldehyde oxidase inhibitor
0,477  0,033  Vasodilator, peripheral
0,473  0,030  Ulceration
0,461  0,031  Antipsychotic
0,429  0,008  GST M1-1 substrate
0,462  0,044  Histamine release inhibitor
0,423  0,007  Pneumotoxic
0,440  0,025  Cardiovascular analeptic
0,435  0,036  FMO1 substrate
0,415  0,030  Sensitization
0,421  0,036  Spasmolytic
0,421  0,039  CYP2D6 substrate
0,420  0,059  Antipruritic, allergic
0,376  0,019  5 Hydroxytryptamine uptake stimulant
0,358  0,003  Antihypermotility
0,428  0,077  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,407  0,060  CYP2C9 substrate
0,345  0,003  Melatonin 2 agonist
0,337  0,004  Hearing loss treatment
0,331  0,004  GABA C receptor rho-2 antagonist
0,370  0,044  CTGF expression inhibitor
0,336  0,009  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,364  0,039  CYP1A2 inhibitor
0,390  0,065  CYP3A4 substrate
0,340  0,019  Tyrosine 3 hydroxylase inhibitor
0,384  0,064  Cognition disorders treatment
0,353  0,035  Urologic disorders treatment
0,324  0,008  Carcinogenic, group 1
0,318  0,004  5 Hydroxytryptamine 3E antagonist
0,365  0,054  Anxiolytic
0,349  0,043  NOS2 expression inhibitor
0,352  0,046  UGT1A9 substrate
0,319  0,023  Urinary incontinence treatment
0,327  0,032  Cyclic AMP phosphodiesterase inhibitor
0,298  0,005  Constipation treatment
0,308  0,016  CYP2B6 inhibitor
0,314  0,025  Sleep disorders treatment
0,318  0,029  Sedative
0,335  0,048  UGT2B4 substrate
0,306  0,019  Irritable Bowel syndrome treatment
0,331  0,046  Antipyretic
0,326  0,043  Amyotrophic lateral sclerosis treatment
0,342  0,062  Caspase 3 stimulant
0,292  0,014  NADPH oxidase inhibitor
0,285  0,007  Phobic disorders treatment
0,311  0,035  Peroxidase inhibitor
0,318  0,045  Superoxide dismutase inhibitor
0,315  0,046  Flavin-containing monooxygenase substrate
0,273  0,005  GABA C receptor antagonist
0,281  0,014  Succinate dehydrogenase inhibitor
0,288  0,021  Neurotrophic factor enhancer
0,402  0,138  Antiinflammatory
0,266  0,003  Melatonin agonist
0,328  0,067  Vasodilator, coronary
0,326  0,068  Calcium channel activator
0,282  0,026  Antipruritic, non-allergic
0,259  0,004  GST T1-1 substrate
0,264  0,011  Excitatory amino acid transporter EAAC1 inhibitor
0,316  0,064  Lipoxygenase inhibitor
0,272  0,020  CNS active muscle relaxant
0,269  0,020  3C-like protease (Human coronavirus) inhibitor
0,289  0,040  Antiparkinsonian, rigidity relieving
0,349  0,100  TNF expression inhibitor
0,259  0,010  Antiemetic
0,314  0,069  Respiratory analeptic
0,265  0,020  Alpha-N-acetylglucosaminidase inhibitor
0,268  0,024  Attention deficit/hyperactivity disorder treatment
0,284  0,043  Antiarrhythmic
0,305  0,066  CYP1A2 substrate
0,245  0,007  5 Hydroxytryptamine 1A agonist
0,253  0,016  Aldose reductase substrate
0,241  0,005  Dyspepsia treatment
0,241  0,005  GABA C receptor rho-1 antagonist
0,258  0,024  Protein kinase stimulant
0,297  0,065  FMO3 substrate
0,248  0,017  Neuropathy treatment
0,266  0,036  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,277  0,048  5 Hydroxytryptamine 1E antagonist
0,250  0,022  Genotoxic
0,278  0,050  Gastrin inhibitor
0,254  0,028  Diabetic nephropathy treatment
0,234  0,009  Nav1.5 sodium channel blocker
0,260  0,035  Male reproductive disfunction treatment
0,255  0,030  Acaricide
0,283  0,059  Hypoglycemic
0,239  0,018  SULT1A3 substrate
0,283  0,066  Transcription factor STAT inhibitor
0,294  0,077  Nootropic
0,224  0,008  Gastritis treatment
0,257  0,042  VCAM1 expression inhibitor
0,239  0,024  Aldehyde oxidase substrate
0,273  0,058  Potassium channel (Voltage-sensitive) blocker
0,228  0,014  Alpha 2 adrenoreceptor antagonist
0,216  0,002  Sodium/hydrogen exchanger 5 inhibitor
0,227  0,013  Arachidonic acid antagonist
0,251  0,038  Antimutagenic
0,223  0,011  Beta amyloid protein antagonist
0,214  0,003  Melatonin 1 agonist
0,234  0,023  Insulin secretagoues
0,284  0,074  Hypoxia-inducible factor 1 alpha inhibitor
0,279  0,070  Huntington's disease treatment
0,324  0,115  15-Lipoxygenase inhibitor
0,257  0,050  Chemopreventive
0,253  0,047  RNA-directed DNA polymerase inhibitor
0,247  0,042  UGT1A4 substrate
0,221  0,017  Carcinogenic, group 2B
0,223  0,018  Antirickettsial
0,287  0,083  Analeptic
0,227  0,024  Bipolar disorder treatment
0,234  0,032  MAO inhibitor
0,214  0,011  5 Hydroxytryptamine 3A agonist
0,342  0,141  MAP kinase 1 inhibitor
0,226  0,029  5 Hydroxytryptamine antagonist
0,259  0,063  HERG channel blocker
0,242  0,046  Non-steroidal antiinflammatory agent
0,255  0,059  UGT1A6 substrate
0,204  0,009  Carcinogenic, group 2A
0,199  0,006  mTOR complex 1 inhibitor
0,320  0,127  Analgesic
0,197  0,004  Glutamate (mGluR7) agonist
0,244  0,051  Platelet adhesion inhibitor
0,215  0,023  Mannose-6-phosphate isomerase inhibitor
0,215  0,023  Adenylate cyclase inhibitor
0,216  0,027  5 Hydroxytryptamine 2 antagonist
0,240  0,051  Abortion inducer
0,223  0,035  UGT2B15 substrate
0,246  0,058  Antihypotensive
0,262  0,075  Transcription factor STAT3 inhibitor
0,233  0,046  Nitric-oxide synthase stimulant
0,208  0,023  Antiadrenergic
0,208  0,025  Glutathione S-transferase substrate
0,299  0,115  Calpain 2 inhibitor
0,206  0,022  Adrenaline antagonist
0,194  0,011  Antineoplastic (uterine cancer)
0,186  0,004  5 Hydroxytryptamine 2A agonist
0,211  0,030  UGT2B10 substrate
0,216  0,036  VEGF expression inhibitor
0,217  0,037  Antiparkinsonian, tremor relieving
0,247  0,068  Calpain inhibitor
0,234  0,055  Antiviral (West Nile virus)
0,184  0,005  mTOR complex 2 inhibitor
0,264  0,086  Antihypoxic
0,199  0,021  GABA C receptor agonist
0,190  0,012  5 Hydroxytryptamine 1 agonist
0,200  0,024  MAO B inhibitor
0,210  0,035  Carcinogenic, group 3
0,187  0,013  Creatine kinase inhibitor
0,280  0,106  Transcription factor NF kappa B inhibitor
0,194  0,020  5 Hydroxytryptamine 2A antagonist
0,177  0,004  5 Hydroxytryptamine 2 agonist
0,215  0,043  UGT1A3 substrate
0,218  0,046  Lipocortins synthesis antagonist
0,223  0,052  UGT2B7 substrate
0,207  0,038  Skeletal muscle relaxant
0,191  0,024  Antismoking
0,173  0,008  Antiviral (Rhinovirus)
0,214  0,051  Histone acetyltransferase inhibitor
0,226  0,063  Antialcoholic
0,180  0,017  Alpha 2a adrenoreceptor antagonist
0,232  0,069  Antiparasitic
0,174  0,012  Alpha adrenoreceptor agonist
0,168  0,007  Restless leg syndrome treatment
0,171  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,188  0,029  CF transmembrane conductance regulator agonist
0,257  0,099  NOS3 expression inhibitor
0,163  0,005  Alpha 2 adrenoreceptor agonist
0,235  0,078  Antiamyloidogenic
0,187  0,030  Alpha adrenoreceptor antagonist
0,168  0,011  Acetylcholine M3 receptor agonist
0,240  0,083  Antihypercholesterolemic
0,198  0,042  Melanin inhibitor
0,169  0,012  CYP2A6 inhibitor
0,170  0,015  Actinic keratosis treatment
0,217  0,062  UGT1A1 substrate
0,231  0,076  Cardiodepressant
0,176  0,021  Antiprotozoal (Babesia)
0,193  0,040  CDC-like kinase 1 inhibitor
0,163  0,010  Antidote, mercury
0,171  0,020  5 Hydroxytryptamine 1 antagonist
0,194  0,043  UGT2B9 substrate
0,191  0,040  Antidiarrheal
0,164  0,014  5 Hydroxytryptamine uptake inhibitor
0,211  0,062  I kappa B kinase epsilon inhibitor
0,240  0,092  Chemoprotective
0,242  0,093  Radiosensitizer
0,195  0,048  Phospholipase C inhibitor
0,171  0,025  Alpha 2c adrenoreceptor antagonist
0,164  0,018  Ca2+-transporting ATPase inhibitor
0,249  0,105  CYP2D6 inhibitor
0,189  0,044  Erectile dysfunction treatment
0,165  0,020  DNA repair enzyme inhibitor
0,167  0,023  Dopamine antagonist
0,159  0,016  Electron transport complex I inhibitor
0,177  0,034  MAO A inhibitor
0,189  0,048  Interleukin 6 antagonist
0,155  0,014  Dopamine D3 antagonist
0,172  0,031  GST P1-1 substrate
0,154  0,014  Estrogen receptor beta antagonist
0,189  0,049  Hair growth stimulant
0,164  0,025  UDP-glucose 4-epimerase inhibitor
0,201  0,062  Sepsis treatment
0,185  0,047  Interferon gamma antagonist
0,225  0,088  DNA synthesis inhibitor
0,156  0,020  Myasthenia Gravis treatment
0,231  0,095  Cardiotonic
0,157  0,022  Dopamine D2 antagonist
0,183  0,049  Catenin beta inhibitor
0,278  0,145  Analgesic, non-opioid
0,149  0,017  Acetylcholine release stimulant
0,152  0,020  DOPA decarboxylase inhibitor
0,182  0,051  Antiischemic, cerebral
0,198  0,068  Antihelmintic
0,171  0,042  Sodium channel (voltage-gated) blocker
0,186  0,057  Antianorexic
0,133  0,005  Potassium channel Kv1.3 blocker
0,148  0,020  CDC-like kinase 3 inhibitor
0,198  0,071  Carcinogenic
0,141  0,014  Tourette's syndrome treatment
0,241  0,114  12-Lipoxygenase inhibitor
0,155  0,028  Antiviral (Papilloma)
0,162  0,036  Cystathionine beta-synthase inhibitor
0,149  0,023  Estrogen antagonist
0,160  0,035  Alpha 2b adrenoreceptor antagonist
0,211  0,086  Potassium channel blocker
0,148  0,023  Prolactin inhibitor
0,145  0,021  5 Hydroxytryptamine 1A antagonist
0,235  0,111  Insulysin inhibitor
0,158  0,035  5-Lipoxygenase inhibitor
0,169  0,045  Sodium channel blocker
0,156  0,033  SULT1A1 substrate
0,170  0,047  Nav1.2 sodium channel blocker
0,187  0,064  Muscle relaxant
0,222  0,100  Proliferative diseases treatment
0,149  0,029  Antiviral (Influenza B)
0,189  0,068  Antiviral (Hepatitis)
0,132  0,014  Female sexual dysfunction treatment
0,131  0,012  Narcolepsy treatment
0,135  0,017  Dopamine D1 antagonist
0,135  0,017  Keratolytic
0,126  0,009  Secretase beta inhibitor
0,176  0,060  Antiviral (Hepatitis C)
0,162  0,045  Adenylate cyclase stimulant
0,245  0,129  Cholesterol antagonist
0,157  0,042  Antihelmintic (Trematoda)
0,128  0,014  Leukotriene synthesis inhibitor
0,131  0,019  Ornithine decarboxylase inhibitor
0,178  0,065  Antineoplastic (bone cancer)
0,175  0,062  Eye irritation, high
0,242  0,130  ICAM1 expression inhibitor
0,128  0,016  Estrogen receptor alpha antagonist
0,144  0,033  Carbonic anhydrase XV inhibitor
0,141  0,030  Antifungal (Pneumocystis)
0,151  0,040  5 Hydroxytryptamine 2B antagonist
0,123  0,014  Granulocyte macrophage colony stimulating factor agonist
0,121  0,012  Prokinetic
0,115  0,006  Antidote, organophosphates
0,214  0,105  Antioxidant
0,126  0,019  Dopamine agonist
0,151  0,045  Antihemorrhagic
0,114  0,008  Phosphodiesterase VIII inhibitor
0,211  0,107  DNA damaging
0,283  0,178  Antidiabetic
0,283  0,178  Cyclophilin D inhibitor
0,138  0,034  Transcription factor STAT6 inhibitor
0,138  0,036  Antihelmintic (Fasciola)
0,134  0,032  Sphingomyelinase inhibitor
0,146  0,044  Coagulant
0,217  0,115  Antineurogenic pain
0,128  0,028  Triose-phosphate isomerase inhibitor
0,114  0,014  Alpha 1 adrenoreceptor agonist
0,139  0,039  TRPA1 agonist
0,133  0,033  Alpha 1 adrenoreceptor antagonist
0,217  0,117  CYP2C19 substrate
0,233  0,133  CYP3A4 inhibitor
0,116  0,016  Caspase 7 inhibitor
0,261  0,162  CYP2C19 inhibitor
0,213  0,114  Radioprotector
0,104  0,006  5 Hydroxytryptamine 4 antagonist
0,198  0,099  Dyrk kinase inhibitor
0,112  0,014  Phosphodiesterase VI inhibitor
0,201  0,104  Vasodilator
0,137  0,040  Photosensitizer
0,128  0,030  Posttraumatic stress disorder treatment
0,134  0,037  Mediator release inhibitor
0,122  0,025  Gastroesophageal reflux disease treatment
0,133  0,036  Carbonic anhydrase III inhibitor
0,185  0,089  Psychostimulant
0,150  0,053  Pregnane X receptor agonist
0,105  0,009  Peristaltic stimulant
0,114  0,018  5 Hydroxytryptamine 1B antagonist
0,100  0,004  Ryanodine receptor antagonist
0,128  0,034  Acetylcholine agonist
0,125  0,030  UGT2B11 substrate
0,115  0,021  Phosphodiesterase V inhibitor
0,103  0,009  Glutamate (mGluR7) antagonist
0,126  0,034  Mental retardation treatment
0,099  0,008  5 Hydroxytryptamine 2C agonist
0,126  0,036  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,107  0,016  Acetylcholine M5 receptor agonist
0,195  0,105  Aryl hydrocarbon receptor agonist
0,094  0,004  Delayed rectifier potassium channel blocker
0,119  0,030  Alpha 1a adrenoreceptor antagonist
0,120  0,031  Lanosterol 14 alpha demethylase inhibitor
0,143  0,054  Antihyperlipoproteinemic
0,125  0,036  Hedgehog signaling inhibitor
0,120  0,031  Paget's disease treatment
0,147  0,059  Psychosexual dysfunction treatment
0,093  0,005  Dopamine D5 agonist
0,158  0,070  Diuretic
0,115  0,028  Adrenaline agonist
0,117  0,030  NADH dehydrogenase inhibitor
0,176  0,089  Anesthetic general
0,166  0,079  Mutagenic
0,137  0,052  Cholesterol synthesis inhibitor
0,101  0,016  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,097  0,012  Glutamate (mGluR6) antagonist
0,134  0,050  Contraceptive female
0,089  0,005  Adenylate cyclase 1 inhibitor
0,125  0,041  Antineoplastic, alkylator
0,186  0,102  Teratogen
0,101  0,017  5 Hydroxytryptamine 3 antagonist
0,100  0,016  5 Hydroxytryptamine 3A antagonist
0,124  0,040  Obsessive-compulsive disorder treatment
0,137  0,054  Vanilloid 1 agonist
0,090  0,007  Anesthetic inhalation
0,172  0,091  UDP-glucuronosyltransferase substrate
0,085  0,004  Dopamine autoreceptor agonist
0,218  0,138  Bone diseases treatment
0,122  0,042  Adenylate kinase inhibitor
0,149  0,069  Thiol protease inhibitor
0,132  0,053  Sphingosine 1-phosphate receptor 4 antagonist
0,101  0,022  5 Hydroxytryptamine 1D antagonist
0,085  0,006  Antihyperaldosteronism
0,146  0,068  Sphingosine 1-phosphate receptor 5 antagonist
0,119  0,040  Anabolic
0,145  0,067  Amylase inhibitor
0,156  0,078  Uterine stimulant
0,126  0,049  Mucolytic
0,080  0,004  Melatonin receptor 1A agonist
0,108  0,032  Bromodomain-containing protein 2 inhibitor
0,116  0,040  Electrolyte absorption antagonist
0,080  0,004  Sodium/glucose cotransporter 2 inhibitor
0,170  0,094  Antimigraine
0,188  0,112  Cytostatic
0,094  0,018  Acetylcholine muscarinic agonist
0,106  0,032  Macrophage migration inhibitory factor inhibitor
0,104  0,030  Phosphofructokinase-1 inhibitor
0,126  0,052  Shock treatment
0,107  0,033  Glutamate release inhibitor
0,107  0,034  NAD(P)H dehydrogenase (quinone) inhibitor
0,093  0,020  Alcohol oxidase inhibitor
0,096  0,023  Glycine receptor agonist
0,091  0,019  Protein kinase C beta inhibitor
0,175  0,103  Embryotoxic
0,153  0,081  Cystic fibrosis treatment
0,132  0,060  Aldehyde dehydrogenase inhibitor
0,083  0,011  Potassium channel (Inward rectifier) blocker
0,092  0,020  Endocannabinoid uptake inhibitor
0,104  0,034  Porphobilinogen synthase inhibitor
0,163  0,092  DNA methyltransferase I inhibitor
0,087  0,017  SULT2A1 substrate
0,129  0,059  Proteasome inhibitor
0,101  0,031  Glycine receptor antagonist
0,125  0,055  Microtubule formation inhibitor
0,097  0,027  Dopamine D4 antagonist
0,234  0,165  Antiasthmatic
0,074  0,005  Melatonin antagonist
0,182  0,113  Free radical scavenger
0,116  0,047  Chronic obstructive bronchitis treatment
0,084  0,015  Acetylcholine M1 receptor agonist
0,080  0,012  5 Hydroxytryptamine 1B agonist
0,120  0,053  Ferrochelatase inhibitor
0,130  0,063  Cathepsin H inhibitor
0,085  0,019  Antiviral (Parainfluenza)
0,220  0,154  Antithrombotic
0,070  0,004  Glutamate (mGluR1a) agonist
0,079  0,014  Aconitate hydratase inhibitor
0,071  0,006  5 Hydroxytryptamine 2B agonist
0,070  0,005  Guanylate cyclase inhibitor
0,117  0,052  AMP-activated protein kinase stimulant
0,105  0,041  Phosphodiesterase IV inhibitor
0,089  0,025  Bulimia treatment
0,100  0,037  Phosphodiesterase 4D inhibitor
0,082  0,019  Antihemophilic
0,081  0,018  Fatty acid synthase inhibitor
0,100  0,037  Acetylcholine nicotinic agonist
0,097  0,035  Na+ K+ transporting ATPase inhibitor
0,072  0,010  Retinoid X receptor agonist
0,077  0,016  Leukotriene B4 antagonist
0,091  0,031  Phosphodiesterase 5A inhibitor
0,066  0,006  Integrin alpha2 antagonist
0,064  0,004  Sodium/glucose cotransporter inhibitor
0,174  0,115  Antiviral (Ebola)
0,099  0,040  MAP-kinase-activated kinase inhibitor
0,062  0,003  Imidazoline I1 receptor antagonist
0,133  0,074  Antifungal enhancer
0,168  0,109  Insulin sensitizer
0,119  0,060  Skin irritative effect
0,072  0,014  Mineralocorticoid receptor antagonist
0,104  0,045  Calcium antagonist
0,191  0,134  Antiosteoporotic
0,070  0,012  Glucose-6-phosphate isomerase inhibitor
0,070  0,012  Progesterone antagonist
0,071  0,014  Aldosterone antagonist
0,091  0,034  NAT1 substrate
0,076  0,020  Nicotinic alpha7 receptor agonist
0,118  0,063  Monophenol monooxygenase inhibitor
0,130  0,074  Sphingosine 1-phosphate receptor 2 antagonist
0,090  0,035  MAP-kinase-activated kinase 2 inhibitor
0,135  0,080  Cell wall synthesis inhibitor
0,071  0,017  Dopamine D2 agonist
0,126  0,071  Cyclooxygenase 3 inhibitor
0,127  0,073  Cyclooxygenase 1 inhibitor
0,068  0,014  Growth hormone secretagogue receptor agonist
0,059  0,005  Melatonin 1 antagonist
0,149  0,095  Nitric oxide antagonist
0,105  0,050  HIV-1 integrase (Overall Integration) inhibitor
0,065  0,011  Dopamine beta hydroxylase inhibitor
0,082  0,028  Carbamoyl phosphate synthetase inhibitor
0,064  0,010  5 Hydroxytryptamine 3B antagonist
0,090  0,037  Acetylcholine M4 receptor antagonist
0,091  0,038  Estrogen-related receptor beta agonist
0,083  0,030  Hyperparathyroidism treatment
0,113  0,059  Choleretic
0,073  0,019  Thromboxane A2 antagonist
0,059  0,006  MAP3K5 inhibitor
0,080  0,028  Gaucher disease treatment
0,080  0,028  Cannabinoid CB1 receptor agonist
0,068  0,016  Leukotriene C antagonist
0,125  0,073  Toll-Like receptor 2 antagonist
0,079  0,027  Exportin-1 inhibitor
0,075  0,023  Thromboxane antagonist
0,066  0,015  Sodium/calcium exchanger inhibitor
0,119  0,068  Acetylcholine muscarinic antagonist
0,076  0,026  Androgen agonist
0,109  0,059  UGT2B1 substrate
0,136  0,086  Antianemic
0,084  0,034  Vanilloid 4 agonist
0,074  0,024  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,103  0,053  MAP kinase kinase 1 inhibitor
0,081  0,031  Leukotriene antagonist
0,122  0,072  Antiseptic
0,107  0,058  Urease inhibitor
0,130  0,081  Nav1.6 sodium channel blocker
0,083  0,034  Carbonic anhydrase V inhibitor
0,203  0,155  Prostaglandin dehydrogenase inhibitor
0,070  0,022  Postcoital contraceptive
0,078  0,030  Orexin receptor antagonist
0,116  0,068  Calcium channel N-type blocker
0,051  0,003  Alpha 2b adrenoreceptor agonist
0,088  0,041  Interferon agonist
0,227  0,179  Antiobesity
0,066  0,019  Glutamate (mGluR group I) agonist
0,052  0,004  Integrin alpha2beta1 antagonist
0,081  0,034  S-adenosyl-L-methionine decarboxylase inhibitor
0,157  0,110  Pyruvate kinase inhibitor
0,205  0,159  Antiallergic
0,153  0,107  LDLR expression enhancer
0,060  0,014  Purinergic P2X4 antagonist
0,091  0,045  Carbonic anhydrase VI inhibitor
0,093  0,047  Antispirochetal
0,090  0,044  D-Ala-D-Ala ligase inhibitor
0,081  0,036  Carbonic anhydrase VA inhibitor
0,232  0,186  CYP2C9 inhibitor
0,083  0,038  MAP kinase kinase 7 inhibitor
0,094  0,049  5 Hydroxytryptamine 2C antagonist
0,058  0,013  GABA B receptor antagonist
0,076  0,031  Aryl hydrocarbon receptor antagonist
0,075  0,031  Protease 3C (Human rhinovirus) inhibitor
0,160  0,116  Focal adhesion kinase 2 inhibitor
0,058  0,014  Cytokine production stimulant
0,051  0,008  Vanilloid 3 antagonist
0,051  0,008  ATM kinase inhibitor
0,073  0,029  Collagenase 3 inhibitor
0,097  0,054  ABCA1 expression enhancer
0,056  0,012  Retinoid X alpha receptor agonist
0,096  0,053  SULT1E1 substrate
0,052  0,009  Sodium-dependent vitamin C transporter 2 inhibitor
0,139  0,097  Movement disorders treatment
0,058  0,016  DNA-dependent protein kinase inhibitor
0,155  0,113  DNA methylase inhibitor
0,061  0,019  Potassium channel (Inward rectifier) activator
0,072  0,030  Purinergic P2X1 antagonist
0,073  0,032  Aromatase inhibitor
0,066  0,024  Nicotinic receptor alpha7 subunit antagonist
0,045  0,004  Melatonin receptor 1A antagonist
0,056  0,015  Antiviral (Enterovirus)
0,047  0,006  Estrogen-related receptor beta antagonist
0,134  0,093  Heat shock protein 90 antagonist
0,079  0,038  Phenylalanine 4-hydroxylase inhibitor
0,077  0,036  Nav1.7 sodium channel blocker
0,104  0,064  Antifungal (Aspergillus)
0,113  0,072  Anesthetic local
0,131  0,091  Cytidine deaminase inhibitor
0,178  0,138  Chronic obstructive pulmonary disease treatment
0,092  0,053  Androgen antagonist
0,052  0,012  Sirtuin 2 inhibitor
0,175  0,135  Antidiabetic symptomatic
0,066  0,027  Phosphatidylinositol 3-kinase gamma inhibitor
0,058  0,018  Potassium channel (ATP-sensitive) activator
0,146  0,106  Tumour necrosis factor antagonist
0,199  0,160  AR expression inhibitor
0,043  0,005  Sodium/glucose cotransporter 1 inhibitor
0,067  0,029  Beta 1 adrenoreceptor antagonist
0,067  0,030  Nicotinic neuronal receptor agonist
0,086  0,048  Thioredoxin reductase inhibitor
0,077  0,040  Orexin receptor 1 antagonist
0,067  0,030  Potassium channel intermediate-conductance Ca-activated blocker
0,068  0,032  Calcium channel P-type blocker
0,071  0,035  5 Hydroxytryptamine 3 agonist
0,134  0,099  Heat shock protein 70 antagonist
0,048  0,012  Cholesterol absorption inhibitor
0,063  0,028  Cannabinoid CB2 receptor antagonist
0,051  0,016  DNA gyrase subunit A inhibitor
0,095  0,061  Bile acid receptor antagonist
0,041  0,007  Motilin receptor antagonist
0,050  0,016  TRPM8 blocker
0,216  0,182  Toll-Like receptor 7 agonist
0,079  0,045  Glutamate decarboxylase inhibitor
0,082  0,048  Carbonic anhydrase XIII inhibitor
0,146  0,112  Neurotensin receptor agonist
0,143  0,110  Cytotoxic
0,061  0,028  Dihydroorotate oxidase inhibitor
0,070  0,038  Beta adrenoreceptor antagonist
0,063  0,031  Postmenopausal disorders treatment
0,065  0,033  5 Hydroxytryptamine 6 antagonist
0,175  0,144  Interleukin agonist
0,057  0,025  Topoisomerase II beta inhibitor
0,099  0,067  Antiviral (Poxvirus)
0,042  0,010  Leukotriene B4 receptor 1 antagonist
0,066  0,036  Antimycoplasmal
0,045  0,015  Leukotriene C4 antagonist
0,053  0,023  Nicotinic receptor alpha3 subunit antagonist
0,034  0,004  Alpha 2c adrenoreceptor agonist
0,143  0,114  ATPase inhibitor
0,075  0,046  Histidine decarboxylase inhibitor
0,090  0,061  Potassium channel activator
0,048  0,019  Alpha 1L adrenoreceptor agonist
0,042  0,014  Ceramide glucosyltransferase inhibitor
0,117  0,089  Toll-Like receptor 9 antagonist
0,096  0,068  Aminopeptidase B inhibitor
0,058  0,029  Nicotinic alpha3beta2 receptor antagonist
0,155  0,127  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,074  0,046  Phospholipase D inhibitor
0,098  0,070  Expectorant
0,092  0,064  Potassium channel (Voltage-sensitive) activator
0,058  0,030  Alpha-mannosidase inhibitor
0,085  0,057  Myeloperoxidase inhibitor
0,035  0,008  Melatonin 3 antagonist
0,075  0,048  Potassium channel (Tandem pore domain) blocker
0,067  0,040  Interferon inducer
0,069  0,042  Cannabinoid receptor agonist
0,032  0,005  5 Hydroxytryptamine 4 agonist
0,065  0,038  Phosphodiesterase 1C inhibitor
0,061  0,036  Argininosuccinate synthase inhibitor
0,135  0,110  Muscular dystrophy treatment
0,062  0,036  Dopamine uptake inhibitor
0,033  0,007  Leukotriene B4 receptor 2 antagonist
0,039  0,014  Cholesterol ester transfer protein antagonist
0,086  0,060  Histamine N-methyltransferase inhibitor
0,029  0,003  Imidazoline I2 receptor antagonist
0,075  0,050  Glutamate dehydrogenase inhibitor
0,050  0,025  Glutamate (mGluR5) agonist
0,072  0,048  Peroxisome proliferator-activated receptor gamma antagonist
0,053  0,028  HCV NS3/NS4A protease inhibitor
0,073  0,049  Aminopeptidase I inhibitor
0,058  0,034  Acyl-CoA dehydrogenase inhibitor
0,042  0,019  Glutamate (mGluR8) agonist
0,132  0,108  MAP kinase kinase 4 inhibitor
0,134  0,111  Prostate disorders treatment
0,061  0,038  Glutamate (mGluR1) antagonist
0,045  0,022  Heme oxygenase inhibitor
0,181  0,158  Antidiabetic (type 2)
0,031  0,009  Glutamate (mGluR1) agonist
0,240  0,217  Calcium channel L-type activator
0,062  0,040  Beta 2 adrenoreceptor agonist
0,181  0,158  Neuropeptide Y2 antagonist
0,027  0,005  Follicle-stimulating hormone antagonist
0,211  0,189  Toll-Like receptor agonist
0,125  0,103  Hemostatic
0,036  0,014  Sigma 2 receptor antagonist
0,057  0,035  Glucosylceramidase inhibitor
0,091  0,070  Interleukin 1 beta converting enzyme inhibitor
0,129  0,108  MAP kinase 3 inhibitor
0,081  0,060  Protein kinase A inhibitor
0,056  0,035  Acetylcholine M2 receptor agonist
0,057  0,036  Cannabinoid CB2 receptor agonist
0,026  0,005  NMDA receptor phencyclidine site antagonist
0,094  0,074  NAT2 substrate
0,107  0,087  Cholinergic antagonist
0,042  0,022  Vascular adhesion protein 1 inhibitor
0,093  0,073  Sulfotransferase substrate
0,090  0,071  Xanthine oxidase inhibitor
0,033  0,013  Kynurenine 3 monooxygenase inhibitor
0,057  0,038  Carbonic anhydrase VB inhibitor
0,046  0,027  Glutamate (mGluR group III) antagonist
0,057  0,038  Pregnane X receptor antagonist
0,060  0,041  Biliverdin reductase inhibitor
0,066  0,048  Potassium channel (ATP-sensitive) blocker
0,053  0,035  mTOR inhibitor
0,044  0,026  Nerve growth factor antagonist
0,122  0,104  Antiprotozoal (Coccidial)
0,041  0,023  Farnesoid X receptor agonist
0,222  0,205  Antibacterial
0,104  0,087  Acetylcholine antagonist
0,073  0,056  GABA aminotransferase inhibitor
0,030  0,013  Prostaglandin H2 antagonist
0,052  0,035  Phosphatidylinositol 3-kinase alpha inhibitor
0,050  0,034  Squalene epoxidase inhibitor
0,066  0,050  MDM2 inhibitor
0,129  0,113  Pulmonary hypertension treatment
0,041  0,025  GABA uptake inhibitor
0,053  0,037  Heparanase inhibitor
0,030  0,015  LFA antagonist
0,060  0,045  5 Hydroxytryptamine 5A antagonist
0,044  0,029  Glutamate (mGluR4) antagonist
0,103  0,088  Antineoplastic antimetabolite
0,044  0,029  Glutamate (mGluR group III) agonist
0,064  0,050  Neuronal nicotinic receptor antagonist
0,184  0,170  Antineoplastic (multiple myeloma)
0,068  0,054  Alpha 1b adrenoreceptor antagonist
0,035  0,021  Glucocorticoid antagonist
0,114  0,100  Lipid peroxidase inhibitor
0,080  0,066  Transforming growth factor beta 3 antagonist
0,027  0,014  Acid ceramidase inhibitor
0,058  0,045  Acetylcholine M5 receptor antagonist
0,020  0,007  Prokineticin receptor 1 antagonist
0,039  0,026  G protein-coupled receptor agonist
0,073  0,060  Narcotic antagonist
0,200  0,186  Antineoplastic (breast cancer)
0,024  0,011  Glutaminyl-peptide cyclotransferase inhibitor
0,037  0,024  Inosine monophosphate dehydrogenase inhibitor
0,037  0,025  Histone deacetylase 7 inhibitor
0,089  0,077  Phosphodiesterase 6D inhibitor
0,086  0,073  Protein kinase C zeta inhibitor
0,120  0,108  Acetylcholine M1 receptor antagonist
0,062  0,049  Transcription factor RelA inhibitor
0,057  0,045  Sphingosine kinase inhibitor
0,074  0,062  Acetylcholine nicotinic antagonist
0,041  0,029  Kainate receptor agonist
0,125  0,113  Raynaud's phenomenon treatment
0,200  0,189  Antineoplastic (osteosarcoma)
0,052  0,041  Sphingosine 1-phosphate receptor 5 agonist
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,044  0,033  Mannosidase inhibitor
0,034  0,023  Free fatty acid receptor 1 antagonist
0,112  0,100  Skin whitener
0,058  0,047  Adrenaline uptake inhibitor
0,127  0,116  Heat shock protein 90 alpha antagonist
0,069  0,058  Rho-associated kinase II inhibitor
0,107  0,097  Phosphodiesterase inhibitor
0,044  0,034  Beta adrenoreceptor agonist
0,065  0,055  Prostaglandin-E synthase inhibitor
0,019  0,010  G-protein-coupled receptor 120 agonist
0,042  0,033  Geranyltranstransferase inhibitor
0,034  0,025  Glucose-dependent insulinotropic receptor agonist
0,055  0,046  5 Hydroxytryptamine 5 antagonist
0,051  0,043  CC chemokine 2 receptor antagonist
0,053  0,045  Immunoglobulin Fc receptor antagonist
0,037  0,029  Alpha 1d adrenoreceptor agonist
0,054  0,046  Cathepsin L inhibitor
0,047  0,039  Antiviral (Herpesvirus 3, Human)
0,048  0,040  Beta 2 adrenoreceptor antagonist
0,023  0,015  ICAM 1 antagonist
0,058  0,050  NMDA receptor agonist
0,035  0,027  Glutamate (mGluR3) antagonist
0,025  0,017  Vanilloid 2 agonist
0,070  0,062  Nicotinic alpha4beta2 receptor antagonist
0,018  0,011  Vesicular glutamate transport inhibitor
0,030  0,023  CXC chemokine 3 receptor antagonist
0,105  0,098  Glycogen synthase kinase-3 alpha inhibitor
0,019  0,012  Antibiotic Anthracycline-like
0,105  0,098  Cyclooxygenase 2 inhibitor
0,036  0,030  Retinoid X receptor antagonist
0,027  0,021  Uridine phosphorylase inhibitor
0,013  0,008  Integrin beta2 antagonist
0,032  0,027  Retinoid X alpha receptor antagonist
0,027  0,022  Estrogen-related receptor gamma antagonist
0,105  0,101  Bone formation stimulant
0,028  0,024  Thiazolidinedione
0,082  0,077  Alcohol dehydrogenase inhibitor
0,058  0,054  Histone deacetylase SIRT3 inhibitor
0,031  0,027  Glutamate (mGluR3) agonist
0,090  0,086  Antiprotozoal (Toxoplasma)
0,112  0,109  Cyclooxygenase inhibitor
0,041  0,037  Histamine H1 receptor agonist
0,053  0,049  Phosphatidylinositol kinase inhibitor
0,017  0,013  Free fatty acid receptor 1 agonist
0,025  0,022  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,075  0,072  Inducible nitric-oxide synthase inhibitor
0,068  0,065  Glutamate receptor agonist
0,052  0,049  5 Hydroxytryptamine 7 agonist
0,016  0,013  Telomerase stimulant
0,056  0,053  Phosphodiesterase 1A inhibitor
0,020  0,017  Follicle-stimulating hormone agonist
0,050  0,047  Sphingosine kinase 2 inhibitor
0,026  0,024  Hedgehog signaling activator
0,070  0,068  GABA B receptor agonist
0,025  0,023  5 Hydroxytryptamine 1D agonist
0,035  0,033  Dopamine D3 agonist
0,016  0,015  Cyclin T1 inhibitor
0,040  0,038  Oleamide hydrolase inhibitor
0,026  0,024  HCV NS5A inhibitor
0,013  0,012  Integrin alphaVbeta6 antagonist
0,024  0,023  Nicotinic acid receptor 2 antagonist
0,028  0,028  Nucleoside transporters inhibitor
0,028  0,028  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,008  0,008  Progesterone receptor A antagonist
0,058  0,057  Sphingosine 1-phosphate receptor 4 agonist

